Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 271

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Baseline results of the Depiscan study: A French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR)

Open access
Blanchon, Thierry, Bréchot, Jeanne-Marie, Grenier, Philippe A., Ferretti, Gilbert R., Lemarié, Etienne, Milleron, Bernard, Chagué, Dominique, Laurent, François, Martinet, Yves, Beigelman-Aubry, Catherine, Blanchon, François, Revel, Marie-Pierre, Friard, Sylvie, Rémy-Jardin, Martine, Vasile, Manuela, Santelmo, Nicola, Lecalier, Alain, Lefébure, Patricia, Moro-Sibilot, Denis, Breton, Jean-Luc, Carette, Marie-France, Brambilla, Christian, Fournel, François, Kieffer, Alexia, Frija, Guy, Flahault, Antoine · 2007 · Lung Cancer

Abstract

BACKGROUND Lung cancer has the highest mortality-rate per cancer, with an overall 5-year survival <15%. Several non-randomized studies pointed out the high sensitivity of low dose computed tomography (LDCT) to detect early stage lung cancer. In France, Depiscan, a pilot RCT of LDCT versus chest X-ray (CXR), started on October 2002 to determine the feasibility of enrollment by general practitioners (GPs), investigations and diagnostic procedures by university hospital radiologists and multidisciplinary teams, data management by centralized clinical research assistants, and anticipate the future management of a large national trial. METHODS GPs and occupational physicians (OPs) selected and enrolled 1000 subjects in 1 year. Eligible subjects were asymptomatic males or females aged 50-75 years with a current or former cigarette smoking history of >/=15 cigarettes per day for at least 20 years (former smokers having quit <15 years prior to enrollment). Based to randomization, annual LDCT or CXR screenings were planned at baseline and annually for 2 years. RESULTS Between October 2002 and December 2004, 765 subjects were enrolled by 89 out of the 232 participating GPs and OPs. Complete clinical and imaging baseline data were available for 621 individuals out of the 765 enrolled, due to 144 noncompliant subjects who withdrew their consent. At least one nodule was detected in 152 out of 336 subjects (45.2%) in the LDCT screening, versus 21 out of 285 subjects (7.4%) in the CXR screening arm. Eight lung cancers were detected in the LDCT arm and one in the CXR arm. DISCUSSION This pilot trial allows estimating that non-calcified nodules are 10 [6.36-17.07] times more often detected from LDCT than from CXR. However enrollment by GPs was more difficult than expected with 41% active investigators and a high rate (19%) of noncompliant patients. This experience speaks to the need for a high level of GPs formation and a large, coordinated clinical research team in such a trial. TRIAL REGISTRATION NUMBER 02526.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.lungcan.2007.05.009

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Cited by

See all 271

Metadata

Authors
Blanchon, T., Bréchot, J.-M., Grenier, P. A., Ferretti, G. R., Lemarié, E., Milleron, B., Chagué, D., Laurent, F., Martinet, Y., Beigelman-Aubry, C., Blanchon, F., Revel, M.-P., Friard, S., Rémy-Jardin, M., Vasile, M., Santelmo, N., Lecalier, A., Lefébure, P., Moro-Sibilot, D., Breton, J.-L., Carette, M.-F., Brambilla, C., Fournel, F., Kieffer, A., Frija, G., & Flahault, A.
Venue
Lung Cancer
Publisher
Elsevier BV
Published
2007-10
Volume
58
Issue
1
Pages
50-58
ISSN
0169-5002 (ISSN-L)
OpenAlex
W2115139753
Cited by
271
References
31
FWCI
9.37
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Baseline results of the Depiscan study: A French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR). https://app.cochat.ai/papers/10.1016/j.lungcan.2007.05.009
The paper
Blanchon, T., Bréchot, J.-M., Grenier, P. A., Ferretti, G. R., Lemarié, E., Milleron, B., Chagué, D., Laurent, F., Martinet, Y., Beigelman-Aubry, C., Blanchon, F., Revel, M.-P., Friard, S., Rémy-Jardin, M., Vasile, M., Santelmo, N., Lecalier, A., Lefébure, P., Moro-Sibilot, D., . . . Flahault, A. (2007). Baseline results of the Depiscan study: A French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR). Lung Cancer. https://doi.org/10.1016/j.lungcan.2007.05.009

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.